PearlsInMires Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

PearlsInMires General Information

Description

Developer of pharmaceutical research intended to support the development of therapeutic compounds related to cancer and related conditions. The company offers cancer drugs that investigate molecular compounds and their biological effects, enabling exploration of anticancer drug candidates and related biochemical interventions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building C, Room 1208 Saenggak Factory Dangsan
  • 150 Yeongdeungpo-ro, Yeongdeungpo-gu
  • Seoul, 07292
  • South Korea
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Building C, Room 1208 Saenggak Factory Dangsan
  • 150 Yeongdeungpo-ro, Yeongdeungpo-gu
  • Seoul, 07292
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PearlsInMires Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 01-Jan-2025 Completed Pre-Clinical Trials
5. Accelerator/Incubator 08-Oct-2024 Completed Pre-Clinical Trials
4. Early Stage VC 23-May-2024 Completed Pre-Clinical Trials
3. Accelerator/Incubator 29-Apr-2024 Completed Pre-Clinical Trials
2. Accelerator/Incubator 24-Jan-2024 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jul-2023 Completed Pre-Clinical Trials
To view PearlsInMires’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PearlsInMires Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medinno Partners Venture Capital Minority
BiiG WAVE Accelerator/Incubator
Evergreen Investment Partners (South Korea) Venture Capital Minority
Korea Technology Finance Government Minority
Smilegate Investment Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

PearlsInMires FAQs

  • When was PearlsInMires founded?

    PearlsInMires was founded in 2023.

  • Where is PearlsInMires headquartered?

    PearlsInMires is headquartered in Seoul, South Korea.

  • What industry is PearlsInMires in?

    PearlsInMires’s primary industry is Drug Discovery.

  • Is PearlsInMires a private or public company?

    PearlsInMires is a Private company.

  • What is PearlsInMires’s current revenue?

    The current revenue for PearlsInMires is .

  • Who are PearlsInMires’s investors?

    Medinno Partners, BiiG WAVE, Evergreen Investment Partners (South Korea), Korea Technology Finance, and Smilegate Investment are 5 of 8 investors who have invested in PearlsInMires.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process